Albert Scardino
Biochemistry
Immunovaccine Inc.
Canada
Biography
Albert is a technology and media investor. He has extensive experience as a director of both for-profit and not-for-profit organizations, public and private, in the United States and the United Kingdom. He was a correspondent, commentator and editor for The New York Times, The Guardian, The Independent, the BBC and Sky News. He has served as a communications director in political campaigns and government. He earned his Bachelor’s degree at Columbia University and his Master’s at the University of California, Berkeley. He has been an investor in Immunovaccine since 2005, a director since 2010 and was Chairman of the Board from 2011-2016.
Research Interest
Biochemistry
